Walleye Capital LLC Atara Biotherapeutics, Inc. Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$2.8 - $5.46 $288,120 - $561,834	-102,900 Reduced 53.79%	88,393 $256,000
Q4 2022 Feb 14, 2023	SELL	$2.85 - $5.18 $526,446 - $956,839	-184,718 Reduced 49.13%	191,293 $627,000
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $1.07 Million - $3.28 Million	376,011 New	376,011 $1.42 Million
Q2 2022 Aug 08, 2022	SELL	$4.69 - $9.84 $149,362 - $313,374	-31,847 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$8.44 - $16.89 $268,788 - $537,895	31,847 New	31,847 $296,000
Q1 2020 May 15, 2020	SELL	$5.69 - $17.78 $58,038 - $181,356	-10,200 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$10.89 - $16.79 $111,078 - $171,258	10,200 New	10,200 $168,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.